Navigation Links
Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
Date:10/31/2007

sult of the settlement of various tax disputes. The effective tax rate for the period was 30.7%.

Strong growth in sales of Plavix(R) in the United States resulted in an 83.6% increase in the share of profits of associates to euro 213 million (euro 116 million in the third quarter of 2006). The share of after-tax profits from territories managed by BMS (primarily the United States) under the Plavix(R) and Avapro(R) alliance was euro 141 million, versus euro 56 million in the third quarter of 2006. The contributions from Merial and Sanofi Pasteur MSD also increased relative to the third quarter of 2006.

Minority interests totaled euro 111 million, compared with euro 100 million in the third quarter of 2006. This line includes the share of pre-tax profits paid to BMS from territories managed by sanofi-aventis (euro 107 million, compared with euro 95 million in the third quarter of 2006).

Adjusted net income was up 9.1% at euro 1,853 million, while adjusted earnings per share (adjusted EPS) was euro 1.37 (8.7% up on the 2006 third- quarter figure of euro 1.26), based on an average number of shares outstanding of 1,349.3 million in the third quarter of 2007 and 1,348.0 million in the third quarter of 2006.

Excluding selected items (see Appendix 5), adjusted net income was euro 1,883 million (10.8% up on the 2006 third-quarter figure of euro 1,699 million), and adjusted EPS was euro 1.40 (11.1% up on the 2006 third-quarter figure of euro 1.26).

Expressed in U.S. dollars and excluding selected items, adjusted net income was $2,587 million (19.5% up on the third quarter of 2006), and adjusted EPS was $1.92 (19.3% up on the third quarter of 2006).

9 months to end September 2007

In the nine months to end September 2007, net sales generated by sanofi- aventis totaled euro 21,141 million, a rise of 0.6% on a reported basis.

Gross profit was euro 16,379 million, an increase of 0.4%. The gross margin ratio was 77.5%, versus 77.6% fo
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. Sanofi-Aventis Allows Thais To Make Plavix
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... USA (PRWEB) March 27, 2015 According ... rates of newborns born with Neonatal Abstinence Syndrome (NAS) ... NAS will undergo the painful withdrawal process for a ... body tremors, excessive crying, diarrhea, and vomiting. The condition ... undergoing drug and alcohol addiction treatment (and employing medically ...
(Date:3/27/2015)... London, UK (PRWEB) March 27, 2015 ... that it has appointed Sean Fitzgerald, a former technology ... Chief Operating Officer and Interim Chief Financial Officer. , ... leading education technology innovator, EverFi, backed by Amazon founder ... Twitter founder Evan Williams. Prior to EverFi, he was ...
(Date:3/27/2015)... 2015 SMI (Silicon Microstructures, Inc.), a ... launched the SM1120 MEMS based ultra-miniature pressure sensor designed ... profile at only 220um x 75um provides ample space ... locations. With industry leading in vivo drift performance ... a broad operating pressure range from 0 to 1,100 ...
(Date:3/27/2015)... Diego, CA (PRWEB) March 27, 2015 ... launch its Protect Our Children (POC) NOW! vitamin D ... the Medical University of South Carolina (MUSC), and will ... will be available at no cost to a minimum ... gestation who live within these two service areas. The ...
(Date:3/27/2015)... 2015 California’s ongoing worst ever drought, ... and the United States Northeast, are both manifestations of ... atmosphere is creating changes in the atmosphere’s “energy balance,” ... former NASA researcher, speaking on the Sharon Kleyne Hour™ ... only a warmer and dryer global climate but also ...
Breaking Medicine News(10 mins):Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3
... of two drugs delays disease progression for patients with ... Phase III "ATLAS" trial were presented today by Dr. ... the American Society of Clinical Oncology Annual Meeting. ... whether adding erlotinib (Tarceva), a targeted agent, to maintenance ...
... movers can help reduce risk of serious injury , , SATURDAY, ... movers can help you reduce the risk of injury the ... 20 men who carried a load on a treadmill so ... back, abdomen and forearms. , The study found that carrying ...
... in Heart Failure (HF) syndrome either in stable chronic ... are used to diagnose disease risk, to predict outcome ... a press conference at Heart Failure 2009 in Nice, ... of Cardiology, presented these new findings, namely: , ...
... accessible mini-van and will give it away to a deserving family or ... to ensure this message reaches any family or organization that would benefit ... ... 30, 2009 -- Hyundai of Tempe has acquired a wheelchair ...
... Austin, M.D., founder, Executive Chairman and Chief Medical ... an airplane accident on May 29th, 2009. According ... Sheriff,s Office, his private plane, a Storch two-seater, ... legacy includes leading Arcadian Management Services, a provider ...
... Pharmaceuticals Inc. (Nasdaq: VNDA ) announced today that ... Thursday, August 27, 2009, in Rockville, Maryland. The record ... Only stockholders of record at the close of business ... any adjournment thereof. Vanda anticipates mailing its proxy statement ...
Cached Medicine News:Health News:Study shows drug combination improves outcome for advanced non-small cell lung cancer 2Health News:When It Comes to Lifting, the Pros Have Your Back 2Health News:Novel biomarkers in heart failure 2Health News:Hyundai of Tempe to Giveaway Wheelchair Van to Deserving Family 2Health News:Plane Crash Claims Arcadian's Chairman and Founder, John H. Austin M.D. 2
(Date:3/27/2015)... N.J. , March 27, 2015  Johnson & Johnson ... Shareholders at 10 a.m. (Eastern Time) on Thursday, April 23, ... N.J. Investors and other interested parties ... visiting the Company,s website at www.jnj.com and clicking ... from the meeting will be made available a few hours ...
(Date:3/27/2015)... March 27, 2015 RnRMarketResearch.com ... therapeutic market research report of 52 pages with ... business intelligence library. The report "Visceral ... the therapeutic development for Visceral Pain, complete with ... drug target, mechanism of action (MoA), route of ...
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces the reporting of data ... Melphalan Hydrochloride for Injection with the Delcath Hepatic ... poster presentation at the Society of Surgical Oncology ...
Breaking Medicine Technology:Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
... This evening, Novo Nordisk awarded sponsorships totaling $100,000 to ... people living with type 2 diabetes on how to ... long-term diabetes related complications. The sponsorships are part of ... promote enduring, sustainable change for people living with diabetes. ...
... Cadence Pharmaceuticals, Inc. (NASDAQ: CADX ), ... proprietary product candidates principally for use in the hospital ... corporate overview at the following investment conferences: , ... , Wednesday, September 7, 2011Time:   , 1:30pm Eastern ...
Cached Medicine Technology:Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs 2Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011 2
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
... The unmatched performance of CLS restores ... optimal hemodynamics even when the patient is ... concept of prevention, early detection and restoration ... button) programming and patient management via Home ...
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
Medicine Products: